Orexo
- Biotech or pharma, therapeutic R&D
Orexo is seeking co-development and commercial partners for several of its assets based on its proprietary amorphOX intranasal powder delivery platform. OX640, intranasal epinephrine, is ready for registration trial as 505b2 sumission.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}